244 related articles for article (PubMed ID: 26029047)
1. Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters.
Kang SK; Markowitz GJ; Kim ST; Johnston MV; Kadam SD
Front Cell Neurosci; 2015; 9():173. PubMed ID: 26029047
[TBL] [Abstract][Full Text] [Related]
2. Acute TrkB inhibition rescues phenobarbital-resistant seizures in a mouse model of neonatal ischemia.
Kang SK; Johnston MV; Kadam SD
Eur J Neurosci; 2015 Nov; 42(10):2792-804. PubMed ID: 26452067
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12.
Carter BM; Sullivan BJ; Landers JR; Kadam SD
Sci Rep; 2018 Aug; 8(1):11987. PubMed ID: 30097625
[TBL] [Abstract][Full Text] [Related]
4. Pharmaco-resistant Neonatal Seizures: Critical Mechanistic Insights from a Chemoconvulsant Model.
Kharod SC; Carter BM; Kadam SD
Dev Neurobiol; 2018 Nov; 78(11):1117-1130. PubMed ID: 30136373
[TBL] [Abstract][Full Text] [Related]
5. Rescue of PB-resistant neonatal seizures with single-dose of small-molecule TrkB antagonist show long-term benefits.
Kang SK; Ammanuel S; Adler DA; Kadam SD
Epilepsy Res; 2020 Jan; 159():106249. PubMed ID: 31864171
[TBL] [Abstract][Full Text] [Related]
6. Pre-Clinical Models of Acquired Neonatal Seizures: Differential Effects of Injury on Function of Chloride Co-Transporters.
Kang S; Kadam S
Austin J Cerebrovasc Dis Stroke; 2014; 1(6):. PubMed ID: 25590049
[TBL] [Abstract][Full Text] [Related]
7. High Doses of ANA12 Improve Phenobarbital Efficacy in a Model of Neonatal Post-Ischemic Seizures.
Vyas P; Chaturvedi I; Hwang Y; Scafidi J; Kadam SD; Stafstrom CE
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338726
[TBL] [Abstract][Full Text] [Related]
8. TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice.
Kipnis PA; Sullivan BJ; Carter BM; Kadam SD
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427585
[TBL] [Abstract][Full Text] [Related]
9. Impact of age and strain on ischemic brain injury and seizures after carotid ligation in immature mice.
Comi AM; Trescher WH; Abi-Raad R; Johnston MV; Wilson MA
Int J Dev Neurosci; 2009 May; 27(3):271-7. PubMed ID: 19154784
[TBL] [Abstract][Full Text] [Related]
10. Off-Label Use of Bumetanide for Brain Disorders: An Overview.
Kharod SC; Kang SK; Kadam SD
Front Neurosci; 2019; 13():310. PubMed ID: 31068771
[TBL] [Abstract][Full Text] [Related]
11. Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
Hampel P; Römermann K; Gailus B; Johne M; Gericke B; Kaczmarek E; Löscher W
Neuropharmacology; 2021 Mar; 185():108449. PubMed ID: 33450274
[TBL] [Abstract][Full Text] [Related]
12. Sleep dysfunction following neonatal ischemic seizures are differential by neonatal age of insult as determined by qEEG in a mouse model.
Kang SK; Ammanuel S; Thodupunuri S; Adler DA; Johnston MV; Kadam SD
Neurobiol Dis; 2018 Aug; 116():1-12. PubMed ID: 29684437
[TBL] [Abstract][Full Text] [Related]
13. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
[TBL] [Abstract][Full Text] [Related]
14. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia.
Johne M; Käufer C; Römermann K; Gailus B; Gericke B; Löscher W
Epilepsia; 2021 Jun; 62(6):1460-1471. PubMed ID: 33955541
[TBL] [Abstract][Full Text] [Related]
15. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
Dzhala VI; Brumback AC; Staley KJ
Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures.
Wang S; Zhang XQ; Song CG; Xiao T; Zhao M; Zhu G; Zhao CS
Neuroscience; 2015 Feb; 286():203-15. PubMed ID: 25463517
[TBL] [Abstract][Full Text] [Related]
17. Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model.
Sullivan BJ; Kipnis PA; Carter BM; Shao LR; Kadam SD
Sci Signal; 2021 Nov; 14(708):eabg2648. PubMed ID: 34752143
[TBL] [Abstract][Full Text] [Related]
18. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
19. Effect of Co-administration of Bumetanide and Phenobarbital on Seizure Attacks in Temporal Lobe Epilepsy.
Rahmanzadeh R; Mehrabi S; Barati M; Ahmadi M; Golab F; Kazmi S; Joghataei MT; Seifi M; Gholipourmalekabadi M
Basic Clin Neurosci; 2018; 9(6):408-416. PubMed ID: 30719255
[TBL] [Abstract][Full Text] [Related]
20. NKCC1 transporter facilitates seizures in the developing brain.
Dzhala VI; Talos DM; Sdrulla DA; Brumback AC; Mathews GC; Benke TA; Delpire E; Jensen FE; Staley KJ
Nat Med; 2005 Nov; 11(11):1205-13. PubMed ID: 16227993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
